MSB 3.21% $1.13 mesoblast limited

OMG … So after saying they didn’t like the data and that’s why...

  1. 4,959 Posts.
    lightbulb Created with Sketch. 782
    OMG …

    So after saying they didn’t like the data and that’s why Novartis walked away, we now know that they are still really keen. Not for a partnership which would have been for a pittance, but for a takeover because the SP has crashed and is so ripe for picking now.

    Forget the bad data thing for the moment. Forget there has ever been any inkling Novartis left because the price was too high. Forget that (assuming msb was any good) there is a real risk that after walking away, someone else could swoop in and snap up the stems. forget any common sense.

    Yes, forget all that and I’d say there’s every likelihood Novartis would be back any day now. Only 15 days till all doubt is removed.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.